Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Prospective, Multicenter, Open-label, Controlled, Parallel-group Trial Investigating the Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock - 2

NCT05726825 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT05726825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05726825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Prospective, Multicenter, Open-label, Controlled, Parallel-group Trial Investigating the Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock - 2
Lead sponsor
Hannover Medical School
Phase
Not applicable
Overall status
Recruiting
Start date
February 19, 2025
Completion date
April 30, 2028
Enrollment
274 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock